From Our Partners
Saturday, June 25, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

Advancing Synthetic Chemistry: The DARPA ‘Make It’ Program

by Global Biodefense Staff
June 15, 2015

The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative research proposals to support development of an automated chemical synthesizer that can produce, purify, characterize and scale a wide range of small molecules.

While the field of synthetic chemistry has developed rapidly over the last century, major challenges remain including the slow pace of discovery and limited reproducibility/scalability once a promising new molecule is identified.

Development of an automated chemical synthesis platform capable of synthesizing known and new molecules through continuous, interconnected and scalable reaction, purification, characterization and formulation modules would be a major leap forward for the field.

The Make-It program will specifically address the development of an automated end-to-end system that includes capabilities for:

  • Computational analysis and design of synthetic pathways
  • Reagent/starting material delivery mechanism
  • Interconnected fluidic modules for synthesis and in-line monitoring, purification and formulation
  • The value of synthetic chemistry is omnipresent, ranging from medicines to advanced materials

A successful Make-It system will demonstrate maximal synthetic flexibility using a minimal set of modules by synthesizing several organic small molecule active pharmaceutical ingredients (APIs), including in-line formulation of one API to yield a finished drug product, as well as synthesizing a series of DARPA-defined small molecule challenge targets.

DARPA anticipates that Make-It will completely overhaul the current workflow for chemical design, synthesis and scale-up.

The final program deliverable will be a synthesizer that will utilize software to enable the selection of optimal reaction schemes and tailor process parameters to achieve target yield and purity metrics for a range of desired small molecules. The technology will be inherently scalable from milligram to production levels.

Further details are available via Solicitation Number: DARPA-BAA-15-46. The response deadline is September 1, 2015.

From Our Partners
Tags: BAADARPA

Related Posts

NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents
CBRNE

Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents

April 11, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC